✦ LIBER ✦

Pharmacodynamics of eptifibatide and abciximab in patients with non-ST segment elevation acute coronary syndromes(TAM2)

✍ Scribed by Jorge Saucedo; Luis Garza; Zakaria Matin; Henry K Lui; Guerraumberto J Guerra; Jeffrey W Young; Mary V Jacoski; Lisa K Jennings

Book ID: 119547367
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 284 KB
Volume: 41
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(03)82142-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Pharmacodynamic Evaluation o

Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study

✍ Jorge F. Saucedo; Henry K. Lui; Luis Garza; G. Jose Guerra; Mary V. Jacoski; Lis 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 179 KB

Tirofiban and eptifibatide treatment of

Tirofiban and eptifibatide treatment of patients presenting with acute coronary syndrome with non-ST segment elevation

✍ Corominas, Nuria ;Perez, Joaquin ;Ortiz, Jose ;Ferrer, Elena ;Ribas, Josep ;Sanz 📂 Article 📅 2004 🏛 Springer 🌐 Dutch ⚖ 156 KB

Effect of Abciximab on Clinical and Angi

Effect of Abciximab on Clinical and Angiographic Restenosis in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

✍ Raisuke Iijima; Gjin Ndrepepa; Julinda Mehilli; Josef Dirschinger; Jürgen Pache; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Chronic Kidney Disease in Patients with

Chronic Kidney Disease in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes

✍ Jin H. Han; Abhinav Chandra; Jyotsna Mulgund; Matthew T. Roe; Eric D. Peterson; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Pretreatment with Prasugrel in Non–ST-Se

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

✍ Montalescot, Gilles; Bolognese, Leonardo; Dudek, Dariusz; Goldstein, Patrick; Ha 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 639 KB

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of early eptifibatide for non-ST–segment elevation acute coronary syndromes

✍ Matthew T Roe; Robert H Christenson; E.Magnus Ohman; Raymond Bahr; Francis M Fes 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 121 KB